Healthspan Action Recent News
Some wealthy Americans are spending up to $250,000 a year on longevity care. Here’s what doctors say about the practice
by Renée Onque - CNBC - Entrepreneur Kate Tolo recently made news after revealing publicly that she is following in her boyfriend, Bryan Johnson’s biohacking footsteps. Johnson,...
Miller School of Medicine Stem Cell Research Advances to XPRIZE Healthspan Final
By: Tara Roberts - University of Miami - Research led by Joshua Hare, M.D., helped lay the foundation for laromestrocel, an investigational cell therapy that Longeveron will test...
AI Identifies Signs of Aging in Blood Stem Cells
By Technology Networks - AI model detects aging patterns in blood stem cells from microscope images. Ageing progressively affects the functioning of our body and, among other...
Welcome to the Healthspan Action Coalition (HSAC)
We are a worldwide, cross-sector societal movement helping to establish a new paradigm in medicine
Healthspan Action Coalition (HSAC) supports new medical strategies that intervene in the aging process and offer much better treatment of age-related diseases (dementia, heart disease, cancer, frailty, and many more).
Advancing the Cause of Improving Healthspan
Bringing together science, industry, regulatory bodies and patient advocacy groups with a common goal of relieving human suffering.
Promoting Public Policy for More Longevity research
Supporting legislative action that seeks to address the aging process and its role in virtually all noncommunicable diseases.
Delivering an Increased Healthspan to All Populations
Fighting to remove barriers to healthcare and address the drivers of health inequality for our entire population, both young and old.
The Coalition’s priorities include:
- Increasing government funding for meritorious healthspan research, funding and filling clinical trials.
- Prioritizing an accelerated regulatory process for healthspan treatments and cures, enacting evidence-based regulations that keep pace with innovation.
- Advancing public and private sector payment policies supporting patient access to regenerative medicine and other advanced therapies aimed at extending the healthspan.
- Lessening preclinical animal testing and substituting, where feasible, support for and deployment of advanced technologies, including precision medicine, organ-on-a-chip, AI, organoids and tissue-engineering.
- Addressing the progress, implications and global adoption of updated classifications declaring aging is a disease-related condition.
- Driving workforce development initiatives, including within technical schools and community colleges, to build capacity and develop a skilled workforce for this highly technical field.
- Delivering an increased healthspan to all populations and communities by creating cross-sector collaborations and tools aimed at addressing disparities in the drivers of health and structural flaws in the health system. All people should have the fair and just opportunity to achieve their full potential in every aspect of their health, longevity and well-being.
SUPPORTING HEALTHSPAN INITIATIVES WORLDWIDE

Promoting favorable policy and funding for scientific research, innovations and patient engagement
The coalition unites all stakeholders who have an interest in lessening the burden of diseases and conditions that affect not only the aged, but all patients worldwide who experience an enormous range of health conditions, all of which impact the healthspan.
Organizations
Countries Represented
Combined Leadership Experience















